ecl developing solution (Beyotime)
Beyotime is a verified supplier 
Beyotime manufactures this product 
90
Structured Review
Beyotime
ecl developing solution
Ecl Developing Solution, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+developing+solution/ecl+developing+solution/pm40324967-74-69-72
Average 90 stars, based on 1 article reviews
Ecl Developing Solution, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ecl+developing+solution/ecl+developing+solution/pm40324967-74-69-72
Average 90 stars, based on 1 article reviews
ecl developing solution - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Tris (2-chloroisopropyl) phosphate and Tris (nonylphenyl) phosphite Promote Human Renal Cell Apoptosis through the ERK/CEPBA/Long Non-Coding RNA Cytoskeleton Regulator Axis Article Snippet: After blocking with 5% Article Title: PLAU1 Facilitated Proliferation, Invasion, and Metastasis via Interaction With MMP1 in Head and Neck Squamous Carcinoma Article Snippet: The membranes were then probed with Article Title: Adipocytokine expression, platelet-to-lymphocyte ratio and TGF- β 1/Smad signaling activity in diabetic patients complicated with pulmonary infection. Article Snippet: The membranes were then washed three times and Membrane:Article Title: The natural compound Sanggenon C inhibits PRRSV infection by regulating the TRAF2/NF-κB signalling pathway. Article Snippet: .. The membrane was washed with PBST 3 times and incubated with a secondary antibody at room temperature for 1 h. The membrane was washed with PBST and incubated with Incubation:Article Title: The natural compound Sanggenon C inhibits PRRSV infection by regulating the TRAF2/NF-κB signalling pathway. Article Snippet: .. The membrane was washed with PBST 3 times and incubated with a secondary antibody at room temperature for 1 h. The membrane was washed with PBST and incubated with Article Title: NAT10 Knockdown Improves Cisplatin Sensitivity in Non-Small Cell Lung Cancer by Inhibiting the TRIM44/PI3K/AKT Pathway. Article Snippet: .. The membranes were incubated with the primary antibody against NAT10 (ab194297, Abcam, Cambridge, MA, USA), multidrug resistance 1 (MDR1, ab168337, Abcam), TRIM44 (ab236422, Abcam), phosphorylated phosphoinositide 3- kinase (p- PI3K, 17 366T, CST, Shanghai, China), PI3K (4249T, CST), phosphorylated protein kinase B (p- AKT, 4060T, CST), AKT (9272S, CST), or GAPDH (ab181602, Abcam), followed by immersion of the PVDF membranes into the secondary antibody dilution solution for 1 h. Article Title: NAT10 Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the TRIM44 / PI3K / AKT Pathway Article Snippet: .. The membranes were incubated with the primary antibody against NAT10 (ab194297, Abcam, Cambridge, MA, USA), multidrug resistance 1 (MDR1, ab168337, Abcam), TRIM44 (ab236422, Abcam), phosphorylated phosphoinositide 3‐kinase (p‐PI3K, 17 366T, CST, Shanghai, China), PI3K (4249T, CST), phosphorylated protein kinase B (p‐AKT, 4060T, CST), AKT (9272S, CST), or GAPDH (ab181602, Abcam), followed by immersion of the PVDF membranes into the secondary antibody dilution solution for 1 h. |